Aktiesnakken — Juli 2010
-
jo og jeg kan forstå at de får resultløn og bonus uanset resultatet
-
QEC> hold øje med MACD - ser spændende ud!
http://norma.netfonds.no//analysis.php?paper=QEC.OSE -
novo er steget 50% bare på et halvt år.....tal om risk reward der!
-
-
værst i c20 er det gået for......genmab igen igen
-
not anymore
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind